Pathnova Laboratories
Pathnova Laboratories is a Singapore-based private company founded in 2017 that provides clinical services for scalable detection of nasopharyngeal cancer using machine learning, operating with a small team of 1-10 employees.
- Company typePrivate
- Founded2017
- HeadquartersSingapore, Singapore
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Pathnova Laboratories does
Pathnova Laboratories is a Singapore-based, privately held for-profit company founded in 2017 that operates as a clinic service provider offering scalable detection of nasopharyngeal cancer using machine learning. The company runs with a micro headcount of 1-10 employees and is positioned in the medical diagnostics vertical, specifically targeting nasopharyngeal carcinoma — a cancer with elevated prevalence across Southeast Asia. Its stated value proposition centers on applying ML to enable scalable, clinical-grade detection of this indication, although the specific technical implementation, data sources, model architecture, and clinical evidence base are not disclosed in the available source material.
The company's business model — including pricing mechanics, customer segments, distribution approach, and revenue structure — is not documented in the available data. There is no disclosed revenue, no named customers, no funding history, no management team information, no patents, no certifications or regulatory clearances (for example, HSA Singapore, FDA, or CE Marking), and no partnership or alliance disclosures. Pathnova's public web presence (pathnova.com) currently resolves to a Google Accounts sign-in page rather than substantive company content, suggesting that externally facing material is either behind authentication or not actively maintained, and limiting any third-party verification of product, traction, or operating status.
The evidence base supplied is minimal: a one-paragraph firmographic description, populated blank structured fields across operations, financials, people, products, and partnerships, a confirmed absence of a public API, and no other sourced statements that resolve to specific firmographic facts. Given the absence of disclosed products, customers, revenue, leadership, or capital activity, the company's commercial traction, run-rate, and strategic momentum cannot be assessed from the supplied data.
Pathnova Laboratories firmographics
Firmographics- Name
- Pathnova Laboratories
- Website
- https://pathnova.com
- Company type
- Private
- Founded year
- 2017
- Headcount range
- 1–10 employees
- Short description
- Pathnova Laboratories is a Singapore-based private company founded in 2017 that provides clinical services for scalable detection of nasopharyngeal cancer using machine learning, operating with a small team of 1-10 employees.
- Ownership category
- akta.pro rank
Pathnova Laboratories industry classification
Industry- Product category
- Clinical cancer diagnostics
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Oncology Diagnostics (tumor profiling, MRD, liquid biopsy) (HLAAALAE)
- akta.pro secondary industry
- Oncology Pathways & Precision Medicine Decision Support (HLACAGAH)
Keywords
Where Pathnova Laboratories is headquartered
LocationHeadquarters
- HQ city
- Singapore
- HQ country
- Singapore
- HQ region
- Asia
Markets served
Pathnova Laboratories business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations
Pathnova Laboratories product offering
Product offeringCore offering
Pathnova Laboratories operates as a clinic service provider delivering scalable detection of nasopharyngeal cancer through machine learning. The company pairs physical clinic operations with machine learning models to enable accurate, scalable screening for a specific oncology indication.
Differentiator
Problem solved
Functional benefit
Products and services
- Nasopharyngeal cancer detection service Clinic-based screening and detection service for nasopharyngeal cancer, leveraging machine learning models to support scalable diagnostic workflows for clinical patients and healthcare partners.
Companies that use Pathnova Laboratories
Customer profileIdeal customer profiles1 record
Pathnova Laboratories technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Pathnova Laboratories competitors and assessment
Company assessmentBroad incumbents
- Natera: Natera provides cell-free DNA and molecular testing in oncology (e.g., Signatera MRD) and other areas. Broad oncology diagnostics player with overlapping AI/data science investment.
- Guardant Health: Guardant Health specializes in liquid biopsy and genomics for oncology, including advanced ML/data analytics. Broad oncology diagnostics incumbent operating in adjacent technology space.
- Tempus AI: Tempus operates an AI-enabled precision medicine platform combining data, sequencing, and diagnostics for oncology. A broader incumbent with overlapping ML-based oncology diagnostics capabilities.
- Foundation Medicine: Foundation Medicine provides molecular diagnostics and comprehensive genomic profiling for cancer. A broad oncology diagnostics incumbent adjacent to ML-enabled cancer detection.
Emerging players
- Mindpeak: Mindpeak offers AI-based image analysis for pathology and biomarker quantification. Comparable emerging ML-pathology player with narrower scope than PathAI/Paige.
- Owkin: Owkin applies AI to oncology research and diagnostics, including biomarker discovery and clinical decision support. Comparable in ML-for-oncology positioning with broader biopharma orientation.
Direct peers
- Paige: Paige develops AI-based pathology for cancer detection and diagnosis, including FDA-authorized products. Comparable as an AI-oncology-diagnostics company serving clinical pathology workflows.
- PathAI: PathAI applies machine learning to pathology to improve cancer diagnosis accuracy and supports biopharma and clinical diagnostics. Comparable ML-on-pathology focus targeting cancer detection.
- Lunit: Lunit develops AI solutions for medical imaging and cancer diagnostics, including tissue and biomarker analysis. Comparable ML-based cancer detection product positioning and clinical-lab go-to-market.
- Ibex Medical Analytics: Ibex builds AI-powered cancer diagnostics for pathology, deployed in clinical labs to assist with cancer detection. Closely comparable to Pathnova's ML-based cancer detection service for a specific indication.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat1 record
Key risks5 records
Key highlights4 records
Customer concentration
Pathnova Laboratories social profiles
Digital presencePathnova Laboratories financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pathnova Laboratories leadership team
Management profileNumber of profiles
Pathnova Laboratories funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pathnova Laboratories M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pathnova Laboratories
What does Pathnova Laboratories do?
Pathnova Laboratories operates as a clinic service provider delivering scalable detection of nasopharyngeal cancer through machine learning. The company pairs physical clinic operations with machine learning models to enable accurate, scalable screening for a specific oncology indication.
When was Pathnova Laboratories founded?
Pathnova Laboratories was founded in 2017. It employs 1 to 10 people.
Where is Pathnova Laboratories based?
Pathnova Laboratories is headquartered in Singapore, Singapore, in the Asia region.
Who are Pathnova Laboratories's main competitors?
Broad incumbents on record are Natera, Guardant Health, Tempus AI and Foundation Medicine. Emerging players are Mindpeak and Owkin. Direct peers are Paige, PathAI, Lunit and Ibex Medical Analytics.
Does Pathnova Laboratories have an API?
No public API is recorded for Pathnova Laboratories.
What industry is Pathnova Laboratories in?
Pathnova Laboratories's product category is Clinical cancer diagnostics. Its primary akta.pro industry code is HLAAALAE, Oncology Diagnostics (tumor profiling, MRD, liquid biopsy), with a secondary code of HLACAGAH, Oncology Pathways & Precision Medicine Decision Support. Its NAICS code is 621511 and its SIC code is 8071.